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ier Ltd. AAs for many areas of molecular testing, detection of Geneti-
cally Modified Organisms (GMO) relies on the real-time Poly-
merase Chain Reaction (qPCR) technology. Due to the
increasing number of GMO, a screening approach using qual-
itative screening methods has become an integrated part of
GMO detection. However, specific guidelines for the valida-
tion of these methods are lacking. Here, a pragmatic approach
to conduct in-house and inter-laboratory validation studies for
GMO screening methods, is proposed. Such guidelines could
be adapted to other areas where qualitative qPCR methods are
used for molecular testing allowing to implement easily a
more reliable screening phase where necessary.Background
In many countries, GMO commercialisation is strictly
regulated (Gruere & Rao, 2007; Zel et al., 2012). This im-
plies that each biotech company wishing to bring a GM
event on the market needs to file a dossier for authorisa-
tion/deregulation. In addition, in the European Union
(EU) for example, biotech companies need to make avail-
able the GM material and its conventional counterpart as
well as a reliable detection/quantification method
(Commission Regulation EC/641/2004). Currently, in the
EU the “Golden Standard” for such detection methods is
qPCR. The European Union Reference Laboratory for
GM Food and Feed (EU-RL GMFF) validates these
methods through ring trials with the help of the National
Reference Laboratories (NRL). If the method complies
with the criteria set up by the European Network of
GMO laboratories (European Network of GMO
laboratories [ENGL], 2008), it is made publicly available
(http://gmo-crl.jrc.ec.europa.eu/). Subsequently, it can be
implemented by the GMO detection laboratories (ENGL,
2011a).
In the last years, the number of GM events being com-
mercialised worldwide has been increasing steadily
(James, 2013; Stein & Rodriguez-Cerezo, 2009a). To
date, the International Service for the Acquisition of
Agri-biotech Applications (ISAAA) has counted a total of
336 GM events in 27 crop species being approved for com-
mercialisation, planting and/or for food/feed use (http://
www.isaaa.org/gmapprovaldatabase/ (24/02/2014); James,
2013). In the EU only, to date, 42 single GM events, 20
double stacked events, 4 triple stacked and 1 quadruple
stack events have been authorised under the legislationsll rights reserved.
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food/dyna/gm_register/index_en.cfm; 24/02/2014). Addi-
tionally, the presence of events that are unauthorised in
one country but authorised in another for food and feed
use (further referred to as UGM) may increase in the com-
ing years (Holst-Jensen et al., 2012; James, 2013; Stein &
Rodriguez-Cerezo, 2009b). A one-by-one basis for the
identification of each GM event using event-specific assays
becomes therefore unrealistic. Hence many enforcement
laboratories have established a screening approach which
allows saving time and costs as it aims at drawing conclu-
sions on the presence/absence of as many GM events as
possible using a minimum set of screening qPCR methods
(i.e. taking into account the coverage and discriminative po-
wer of each target).
Hereto the official European laboratories develop their
screening methods in house as they are not taken into
consideration by the EU regulations. Most of the screening
qPCR methods developed at the present time are qualitative
and use SYBRGreen or TaqMan chemistry. They aim at
detecting one element (singleplex) or multiple sequences
simultaneously (multiplex) and can target a taxon-specific
sequence or a GM element (generic and trait) present in
the transgenic construct(s). In addition, construct-specific
qualitative qPCR methods (i.e. targeting the junction be-
tween two GM elements within the transgenic insert) can
be regarded as suitable for screening purposes. Several
such screening methods have been developed by different
laboratories (Bahrdt, Krech, Wurz, & Wulff, 2010;
Barbau-Piednoir et al., 2012; Broeders et al., 2013; De-
bode, Janssen, & Berben, 2013; Dinon et al., 2011; Pansiot
et al., 2011) and are listed in various databases (http://gmo-
crl.jrc.ec.europa.eu/gmomethods/; Dong et al., 2008). Some
screening methods have been validated in collaborative tri-
als (Barbau-Piednoir et al., in press; International Standard
ISO 21569:2005; Jiang et al., 2009), with notable effort of
the Federal Office of Consumer Protection and Food Safety
(Berlin, Germany) and the German working group “Devel-
opment of methods for identifying foodstuffs produced by
means of genetic engineering techniques” (e.g.
Grohmann, Br€unen-Nieweler, Nemeth, & Waiblinger,
2009; Waiblinger, Ernst, Anderson, & Pietsch, 2008). How-
ever, as most of the screening assays are developed by a
single laboratory and as no validation guidelines exist for
qualitative qPCR methods, the development and validation
of these methods lacks harmonisation in contrast to what is
the case for quantitative qPCR methods. An important
consequence thereof is the fact that the specificity as well
as the robustness of screening qPCR assays is generally
not fully verified, with possible important consequences
on the efficacy of the screening phase (Holden, Levine,
Scholdberg, Haynes, & Jenkins, 2010; Morisset et al.,
2009). In the case of multiplex methods, the asymmetric
LOD is a valuable parameter to be addressed in view of
the possible low presence of EU authorised (Regulation
EU/619, 2011) and unauthorised events in a sample. Thereis thus a need for guidelines for the validation of qualitative
screening methods based on qPCR (ENGL, 2011b; Holst-
Jensen et al., 2012; Morisset et al., 2009).
Strategy to develop validation guidelines
When developing and validating in-house qualitative
qPCR methods for GMO screening, most laboratories use
procedures based on general guidelines (Codex
Committee on Methods of Analysis and Sampling
[CCMAS], 2010; European Analytical Chemistry
[EURACHEM], 1998; Food and Agricultural
Organization [FAO], 1998; Thompson, Ellison, & Wood,
2002) or those existing for quantitative qPCR methods
(ENGL, 2008, 2011a). However, these may not be adequate
or respond to the needs for qualitative methods and mainly
comprise theoretical information (i.e. parameters to be eval-
uated and their definition, evaluation criteria) but a precise
experimental setup (material, number of replicates, DNA
amount,.) is often missing. In this study, a team of ex-
perts, gathered within the SAFEFOOD ERANET GMO-
seek project, has analysed the existing documents and
evaluated their usefulness in view of establishing guidelines
for qualitative methods.
The compilation of studied documents included the
Codex Alimentarius Guidelines (CCMAS, 2010), the AF-
NOR norms (Association Franc¸aise de Normalisation
[AFNOR], 2003, 2008), several ISO standards, both general
and GMO-specific ones (International Standard ISO
17025:2005; International Standard ISO 21569:2005;
International Standard ISO 21570:2005; International
Standard ISO 24276:2006; International Standard ISO
5725-2:1994), existing documents for quantitative qPCR
methods (ENGL, 2008, 2011a) as well as a review from
Taverniers, De Loose, and Van Bockstaele (2004). Each
parameter was discussed and an evaluation of its inclusion
in the list of required parameters was made based on the
practical expertise of the partners, the feasibility of the ex-
periments, the use of different chemistries, the time, the
costs and the need for singleplex versus multiplex methods.
Some parameters can be taken over from the quantitative
methods while others need to be adapted, added or are
not of application. A comparison of the parameters to be
considered and the criteria to which they need to comply
for qualitative and quantitative qPCR methods are given
in Table 1.
As it is the case for the ENGL Minimal Performance Re-
quirements document (ENGL, 2008), the parameters to be
evaluated were divided in two groups: method acceptance
parameters (to be tested by the developer during in-house
validation) and method performance parameters (to be eval-
uated via inter-laboratory and collaborative trials). The
different types of screening methods that are being used
by the enforcement laboratories (i.e. singleplex, multiplex,
SYBRGreen, TaqMan) were taken into account. Addi-
tionally, a practical way to perform this evaluation and
the materials to be used are given.
Table 1. Comparison of parameters to be evaluated during valida-
tion of quantitative and qualitative qPCR methods. The criteria are
given between brackets.
Parameter Quantitative
qPCR method
Qualitative
qPCR method
Method acceptance parameters
Applicability þ þ
Practicability þ þ
Specificity þ þ (no false pos/neg)
Sensitivity (LOD)  þ (20 HGE)a
Sensitivity (LOQ) þ (0.9%b
or 0.1%c)

PCR efficiency (ε) þ (90e110%)a Only for multiplex
(80e120%)
Linearity (R2) þ (R2  0.98) Only for multiplex
(R2  0.98)
Accuracy þ 
Trueness þ (25%) 
Precision
(repeatability)
þ (RSDr  25%) 
Robustness þ (30%) þ (correct pos/neg
classification)
Method performance parameters
False positive/
negative rate
 þ (correct pos/neg
classification)
Precision
(reproducibility)
þ (RSDR  25%) 
Measurement
uncertainty
þ (50%) 
þ: parameter to be evaluated; : parameter not to be evaluated;
HGE: haploid genome equivalents; LOD: limit of detection,
LOQ: limit of quantification; RSDr: relative repeatability standard
deviation; RSDR: relative reproducibility standard deviation.
a These values will be adapted to 25 HGE for the LOD and
75e110% for PCR efficiency (personal communication).
b LOQ required for GMO approved according to Regulation EC/
1829 (2003).
c LOQ required for GMO pending for authorisation according to
Regulation EU/619 (2011).
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tive trial validated qualitative methods into the enforcement
laboratories has not been included in this manuscript. The
document established by the ENGL (ENGL, 2011a) can
hereto be used as a guidance.
Practical evaluation of parameters and acceptance
criteria
To evaluate the fitness for purpose of a method and its
performance, several parameters need to be tested. Only
when they comply with the predetermined criteria, a method
can be adopted for routine analysis and can be considered
for further full validation. The definitions of the different pa-
rameters mentioned below can be found in the glossary.
Method acceptance parameters
The following parameters need to be evaluated for both
singleplex and multiplex qualitative qPCR methods during
method development and in-house validation.Applicability
The applicability statement should contain complete in-
formation on the scope of the method i.e. which target,
which matrix and DNA amount have been tested by the
developer. It can be evaluated using different matrices
(raw/processed material, food/feed, genomic (gDNA)/
plasmid (pDNA) DNA). Furthermore, different DNA
amounts can be tested allowing the detection of possible
PCR inhibitors. The results of these tests need to be re-
ported and should give similar results for as many matrices
as possible. Additionally, warnings on the interference with
other analytes and its inapplicability to certain matrices and
conditions should be included when identified.
Practicability
To test the practicability, blind samples can for example
be analysed by the routine laboratory. It allows to check if
the new method can easily be combined with other methods
that are already used in the laboratory and can be run under
the same conditions. Furthermore, the evaluation of the
costs and needs for training of the staff has to be reported.
The practicability can further be evaluated by transferring
the method to a second laboratory where the experiment
can be performed under reproducibility conditions.
A method can be considered as practical when eventual
additional costs are low, training of staff is limited, routine
equipment can beused and the operations are easy to carry out.
Specificity
The specificity of a set of oligonucleotides (i.e. primers
and/or probe) should be checked during method develop-
ment to guarantee that the method only reacts with the tar-
geted sequence. Firstly, this needs to be done in silico by
performing searches against publicly available DNA
sequence databases. Based on this outcome, a first selection
of the designed oligonucleotides can be made. Secondly,
the chosen oligonucleotide sets can be evaluated experi-
mentally by testing them against a set of plant materials,
preferentially (Certified) Reference Materials (CRM).
This set should consist of 20 non-target materials
(including the most important non-transgenic food crops,
as well as all available CRM for GM events that do not
contain the targeted sequence) and 20 target materials if
possible. For taxon-specific screening qPCR methods, ma-
terials from closely related species as well as other species
commonly found in food/feed samples should be included.
Each material should at least be tested in duplicate resulting
in 40 results for each type of sample. According to the
simplified Cochran approach (Cochran, 1977) such test
sample sizes should provide 95% confidence. It should
however be noted that it may not always be possible to
obtain 20 positive materials due to lack of availability of
CRM and/or because the targeted element is only present
in a few GMO. In this case the highest possible number
of positive materials should be tested. This should be
mentioned in the specificity report.
118 S. Broeders et al. / Trends in Food Science & Technology 37 (2014) 115e126The non-target materials should contain at least 1000
haploid genome equivalents (HGE) total DNA. In case
the non-target material is a non-pure GM CRM (i.e. a
CRM with a certified GM% below 100%), at least 100
HGE of the GMO should be present in the reaction to
ensure that cross-reaction will be identified if it occurs.
For the positive materials, the target should be present in
at least 100 HGE to ensure that the element is detectable.
If wished, the target can be measured in a background of
DNA of the same taxon (at for example 1000 HGE). The
HGE can be estimated based on the GM% of the used
CRM, the species genome size (Arumuganathan & Earle,
1991), the ploidy status and the number of inserted copies
in the genome. Alternatively, the absolute copy number
of the targeted sequence can be measured using an event-
specific assay adapted to digital PCR technology
(Morisset, Stebih, Milavec, Gruden, & Zel, 2013).
For methods developed using the SYBRGreen chemis-
try, the melting temperature (Tm) forms beside the Cq value
(quantification cycle) an additional parameter that needs to
be taken into account. Each amplicon has, due to its
sequence, a specific Tm (Ririe, Rasmussen, & Wittwer,False neg rate¼ 100 number misclassified known pos samples
tot number known pos samples
False pos rate¼ 100 number misclassified known neg samples
tot number known neg samples1997). To determine the Tm of the amplicon, the amplified
sequence can be cloned into the pUC18 vector and the
nominal Tm can be determined (e.g. Broeders et al.,
2013). The Tm of the amplicon obtained on the gDNA dur-
ing the specificity test, using the same running conditions,
should be within the interval nominal Tm 1 C to be re-
garded as specific.
The specificity of a qualitative method can further be
checked by confirming the identity of the targeted/ampli-
fied sequence by using appropriate techniques (e.g. ampli-
con sequencing, gel electrophoresis, restriction enzyme
analysis, hybridization techniques; International Standard
ISO 21569:2005).
For multiplex methods, special attention needs to be
given to the generation of additional amplicons (coming
from the fact that for example the forward primer of one
method reacts with the reverse primer of another method)
when designing the primers. This can for instance be eval-
uated by running the obtained PCR products on an agarose
gel or on the Bioanalyzer (Agilent Technologies) or by per-
forming a melting curve analysis.In this context, it should be noted that the available
CRM are intended for use as calibrants and positive control
materials for a specific GM event and not to conduct spec-
ificity tests (Institute for Reference Materials and
Measurements [IRMM], 2006). As a consequence, they
are certified for the content of a certain GM event and
not for the absence of other events nor for the absence/pres-
ence of a specific GM element. Contamination of the used
materials may thus be seen during the specificity test (false
positives). Further confirmation of the presence of another
event can be done by using the validated event-specific
qPCR methods (http://gmo-crl.jrc.ec.europa.eu). In the
case false negative results are observed, a closer analysis
of the targeted sequence should be carried out. It may be
possible that for example a mutation is present at the an-
nealing site of a primer which impairs amplification
(Broothaerts et al., 2008; Morisset et al., 2009).
The results of the specificity test can be expressed as a
percentage of false positives or negatives (CCMAS, 2010)
using the formulae given below. No false positive or nega-
tive results should be seen. If unexpected signals are
observed, they should be further investigated.Sensitivity
The sensitivity of a qPCR method is an important
parameter to evaluate especially in view of the regulation
for GM events pending for authorisation (so called Low
level Presence (LLP) Regulation EU/619, 2011) and for
the detection of UGM which may also be present in low
amounts. The sensitivity of a qualitative qPCR method
can be expressed as the limit of detection (LOD) and two
types of LOD are proposed herein.
The LOD6 is determined experimentally for each qPCR
method by preparing a serial dilution of a positive CRM
and analysing each dilution point in 6-fold (AFNOR,
2008). Optionally, the dilutions can be made in background
DNA. The dilution series should for example cover at least
the following range: 100, 50, 20, 10, 5, 2, 1 and 0.1 HGE.
The last dilution where all six replicates give a positive and
specific amplification (Cq for TaqMan methods, Cq and
Tm for SYBRGreen methods) can be considered as the
LOD6. At least three runs need to be performed under
repeatability conditions, i.e. before each run the dilution se-
ries needs to be prepared freshly and tested in 6-fold
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case the LOD6 of the method is determined as the highest
HGE over all runs. The 0.1 HGE level is tested to verify
that the HGE of the dilution series are approximately cor-
rect. Hereto, not more than one positive result out of the
six replicates should be obtained (AFNOR, 2008). If this
is not the case, the target concentration must be revised.
In addition to the LOD6, the LOD95% needs to be deter-
mined for further confidence of the analytical sensitivity of
the method. Hereto, the HGE corresponding to the LOD6 is
tested in 60 replicates (EU-RL GMFF, 2009) together with
a higher and a lower HGE level. The lowest HGE level at
which all 60 replicates show a specific positive amplifica-
tion is considered as the LOD95% with a 95% confidence
level.
The LOD of a qualitative qPCR method should be equal
or below 20 HGE (AFNOR, 2003). The Cq value corre-
sponding to the LOD can further be introduced in decision
support systems to be used in routine analysis of food and
feed samples (e.g. Broeders, Papazova, Van den Bulcke, &
Roosens, 2012; Van den Bulcke et al., 2010).Robustness
To evaluate the robustness of a qPCR method, different
experimental conditions can be slightly changed and their
impact on the results studied. Such a test is important in
view of the use of the qPCR methods in routine analysis
(e.g. a slight deviation in annealing temperature, small pi-
petting errors,.). In addition, the use of different qPCR in-
struments and master mixes should be evaluated. Such test
can be conducted using for example the fractional factorial
design approach (Youden & Steiner, 1975). The proposed
scheme does not study one alteration at a time, but intro-
duces several changes at once in such a manner that the ef-
fects of the individual changes can be ascertained. This
allows evaluating the robustness in a time- and cost-
effective manner. An example of the way to combine the
different studied factors is given in Table 2.
In each combination, the method is tested using 20 HGE
of the target in at least triplicates in at least one run. To beTable 2. Proposal of a robustness test according to Youden and
Steiner (1975).
Combination No.
Factor value 1 2 3 4 5 6 7 8
A or a A A A A a a A a
B or b B B b b B B B b
C or c C c C c C c C c
D or d D D d d d d D D
E or e E e E e e E E E
F or f F f f F F f f F
G or g G g g G g G G g
A, B, C, D, E, F and G denote the nominal values for seven different
factors that might influence the results if their values were varied
slightly, their alternative values are denoted by a, b, c, d, e, f and g.considered robust, the method should give the expected
result in terms of presence of the target. If this is not the
case, the factors that affect the result should be studied in
detail and eventually adapted to improve the method or to
enable giving the additional information to the users. The
data obtained from this robustness test are mainly informa-
tive and should be reported in the validation dossier to
acknowledge the possible impact of certain factors. Further,
this test needs to be performed on a method-to-method
basis.
Method acceptance parameters specifically for
multiplex methods
In addition to the above mentioned parameters, it is rec-
ommended to test some additional parameters when devel-
oping and validating qualitative multiplex qPCR methods.
The PCR amplification efficiency and linearity can option-
ally also be determined for singleplex methods.
Amplification efficiency (ε)
To calculate the PCR efficiency of a qPCR method, a
dilution series (e.g. 5000, 2500, 1000, 500, 100, 50, 20,
10, 5, 2, 1 and 0.1 HGE) is prepared from a specific positive
material. In the case of a multiplex assay, all the targets
considered in the assay should be set at the same HGE.
This allows to check if competition occurs between the tar-
gets and to evaluate if all perform equally well. Setting all
targets at equal HGE can for example be achieved by mix-
ing different target-containing materials. For practical rea-
sons, a plasmid containing all targeted sequences can be
used to prepare the dilution series. For singleplex methods,
the evaluation can be done using a dilution series of a pos-
itive CRM.
Each dilution point is analysed in 6-fold and four runs
are performed under repeatability conditions, i.e. before
each run the dilutions series needs to be prepared freshly
and each dilution is measured in 6-fold resulting in 24
data for each dilution point. The average Cq values ob-
tained for each point at the upper end of the dilution series
(i.e. 5000 to 100 HGE) are plotted against the log10HGE
and a linear regression analysis is performed. The outcome
of this analysis is an equation of the type y ¼ ax þ b in
which ‘y’ is the plotted Cq value, ‘a’ is the slope of the
regression line, ‘x’ is the log10HGE and ‘b’ is the intercept
of the regression line. Using the slope of the regression line,
the PCR efficiency can be calculated using following
formula:
ε¼ 100 101=slope  1
For each target, the slope of the regression curve, when
using the log10 transformation of the HGE, should be be-
tween 3.9 and 2.9 corresponding to PCR efficiencies
ranging from 80% to 120%. This broader range has been
allowed as the methods are intended for qualitative use,
i.e. present/absent response, and not for quantitative
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ficiencies obtained for each target of the multiplex assay
should not exceed 15% to limit the impact of the possible
competition between the different targets (Huber et al.,
2013). For qualitative singleplex methods, no specific crite-
rion of acceptance for the PCR efficiency is defined. One
can use the criterion as set for quantitative qPCR methods
(Table 1).Linearity (R2)
The experimental setup to determine the linearity for
each qPCR target in a multiplex method is the same as
the one used to determine the PCR efficiency. When per-
forming a linear regression analysis on the obtained data,
excel provides the correlation coefficient R2 of the curve
which is a measure of the linearity of the PCR reaction.
The R2 for each target should be 0.98.
If wished, the linearity for a singleplex method can be
determined in the same way on a positive CRM and using
the same acceptance criterion.Asymmetric LOD (LOD20asym)
The asymmetric LOD needs to be determined for each
target of the multiplex assay. As it might be difficult to pre-
pare such mixes using gDNA extracted from CRM (e.g. due
to unavailability of single target CRM), this analysis can
also be performed using a mix of single target plasmids.
Each target needs to be tested at 20 HGE in a background
of all other targets present at 20,000 HGE totally. Each of
the background targets is set at the same HGE. Twenty
HGE have been chosen for the target under investigation
in relation to the required sensitivity of the methods (i.e.
the LOD should be equal or below 20 HGE) to ensure
that it can still reliably be detected. At least one PCR run
using six replicates is performed for each target. If the
six replicates show a specific amplification, the ratio of 1/
1000 is set as the LOD20asym. If some of the six replicates
are negative, a lower background can be tested, e.g. 20
HGE in a total of 10,000 HGE, and the ratio set as the LO-
D20asym should be adapted (Huber et al., 2013).
For example, in the case three targets are present in the
multiplex assay, in a first experiment the one under investi-
gation for the LOD20asym is set at 20 HGE and the other
two are each set at 10,000 HGE. If one or more replicates
are negative, a new experiment should be set up containing
20 HGE of the target under analysis and the two other tar-
gets at 5000 HGE each.
One can continue to adapt the background (e.g. to ratios
of 1/400, 1/200, 1/100, 1/50) until all six replicates give a
positive signal. If the background needs to be adapted
further and a LOD of 1/50 is reached, it is strongly recom-
mended to find out which of the targets in the multiplex
assay is causing this competition. It will be necessary to re-
check the presence of that target using singleplex qPCR. No
acceptance criterion is set for this parameter. The finalmeasured LOD20asym should be indicated by the method
developer.
Method performance parameters
To enable the developed qPCR screening method to be
recognized internationally, in-house method validation is
not sufficient. A full validation involving different labora-
tories (collaborative trial) needs to be organised. An inter-
mediate step, to obtain an indication on the performance
of the method, can be performed in which the method is
first transferred to at least one laboratory (transferability
study).
Method transferability
When a method is in-house validated and complies with
the set criteria, its transferability to a second laboratory can
be tested. This will allow making a first evaluation of the
performance of the method under different conditions
(other operator, other equipment, etc). Based on the ob-
tained results, the laboratory can decide to go on with the
full validation or not and thus save costs compared to the
direct organisation of the collaborative trial.
For this aim, a false positive/negative test can be per-
formed, as described for the specificity test, using at least
one laboratory and samples containing different levels of
the targeted element. The results can be compared with
those obtained by the developing laboratory. When the
method is found to be performing well, it can be considered
for full validation.
Method full validation in a collaborative trial
Further evaluation of the performance of the method
concerning the detection (i.e. presence/absence) of the spe-
cific target needs to be done via a collaborative trial. As for
the transferability step, the parameter to be studied in this
case is the false positive/negative rate. For this aim, the pro-
cedure as for example used in collaborative studies con-
ducted by the German Federal Office of Consumer
Protection and Food Safety and its working group and
from Grohmann et al. (2009) can be applied.
In this experimental setup, several blind samples need to
be prepared: e.g. three positive samples and one negative
sample. Hereto, a target-containing CRM and its non-
transgenic counterpart can be used, respectively. The nega-
tive sample (0%) should contain for example 200 ng of
taxon-specific DNA. The positive samples should contain
the target (i) at the HGE corresponding to the LOD95%,
(ii) at 0.5 LOD95% (but not below 5 HGE), and (iii) at
2 times LOD95% (but not above 20 HGE), in a background
of for example salmon-sperm DNA (e.g. at 20 ng/ml). Each
blind sample is prepared in 10-fold and analysed in dupli-
cate by at least 12 independent laboratories to ensure ob-
taining a minimum of 100 acceptable results per sample
allowing to calculate the false positive/negative rates with
a 95% confidence level (Macarthur & von Holst, 2012). Re-
sults are considered as acceptable when no deviation to the
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when appropriate statistical tests have been used to exclude
deviating results (e.g. the use of a parametric bootstrap to
check how well the beta binomial model fits the observa-
tions). If wished, additional samples can be prepared and
the experiment can be performed on more than one
target-containing GM event.
It should be noted that when validating taxon-specific
screening methods, the used materials need to be adapted.
The negative sample can be a material from a non-related
species, while the positive samples need to contain the
taxon-specific target as mentioned above.
The false negative and false positive rates can be calcu-
lated as done for the specificity evaluation and both should
be zero. If this is not the case, the reason for it should be
further investigated. In addition, seen the high amount of
data that will be gathered based on this setup, the LOD
of the method can be determined with sufficient confidence
(Macarthur & von Holst, 2012).
Conclusion
The total number of GMO that needs to be detected by
enforcement laboratories is steadily increasing. To reduce
the number of identifications, many GMO detection labora-
tories have established a screening approach in which in-
house developed and validated qualitative qPCR methods
are being used based on a matrix approach (Holst-Jensen
et al., 2012; Kralj Novak et al., 2009; Van den Bulcke
et al., 2010; Waiblinger, Grohmann, Mankertz, Engelbert,
& Pietsch, 2010). These methods are further valuable tools
in the possible detection of UGM. However, their develop-
ment, validation conditions and use are not standardised,
and still remain the subject of individual research and
choice of testing laboratories. This can have important con-
sequences on the correctness of the screening phase and
therefore on the quality of GMO testing.
To remediate to this problem of lack of standardisation, a
group of experts gathered available documents that deal with
validation of qPCR methods. Based on their expertise, a
number of parameters were distilled out of these documents
and adapted to come to a pragmatic and harmonised way of
validating qualitative qPCR methods. In addition, the accep-
tance criteria that need to be met during in-house validation,
to enable declaring the new method as fit for purpose, have
been listed as well as an experimental setup and the most
appropriate material(s) to be used. The established guide-
lines also contain the method performance parameters to
be studied when performing transferability studies and
further going to inter-laboratory validation. An overview is
given in Table 3. The proposed scheme will readily be im-
plemented in the GMOval project (UK Food Standards
Agency contract FS244027) for inter-laboratory validation
of qualitative methods for GMO testing. This will provide
a first indication of its usefulness and application.
Similar to the MIQE guidelines that state the minimum
information for publication of quantitative real-time PCRand digital PCR experiments (Bustin et al., 2009; Huggett
et al., 2013), a template table (Table 4) is provided in which
developers of qualitative qPCR methods can find all rele-
vant experimental conditions and assay characteristics.
Such table should help reviewers evaluating the validity
of their proposed assay for publication and/or collaborative
trial validation.
The current guidelines were designed to provide the
necessary information enabling enforcement laboratories
to develop and validate screening qPCR methods in a
harmonised way (as is done for quantitative qPCR
methods). This is of great value for GMO testing labora-
tories in view of the integration of a screening approach
in routine analysis and thus reducing the cost and time of
the analysis. Additionally, the validation of screening
methods in a standardised way throughout different labora-
tories will ease the adaptation and implementation of these
methods and will allow putting together a set of necessary
methods covering all GM events to be detected. Further-
more, it enables comparing more easily different developed
methods and will lead to the improvement of the screening
phase in GMO detection.
This type of guidelines could also serve as a basis for
other domains of molecular testing where no precise in-
structions exist, to help evaluating the performance and
fitness for purpose of qualitative qPCR methods which
are becoming more and more important.
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The parameters and definitions listed in the glossary are
adopted from the International Standard ISO 24276 (2006)
and the ENGL Minimal Performance Requirements docu-
ment (ENGL, 2008) unless mentioned otherwise.
Method acceptance parameters
The applicability or fitness for purpose of a method re-
fers to the description of the method i.e. the analytes or spe-
cies, the matrices and concentration ranges to which the
method can be applied. It means that information on the
scope of the method needs to be provided and the products
to which it is applicable (ISO 24276, 2006).
The practicability takes into account the ease of opera-
tions, in terms of sample throughput and costs, the feasi-
bility and efficiency of implementation of a new method.
Table 3. Summary on the different method acceptance and performance parameters to be evaluated and their experimental setup.
Parameter Singleplex
methods
Multiplex
methods
Material # PCR
replicates
# PCR
repetitions
(# runs)
Number of copies
(HGE)
Comment
Method acceptance parameters
Applicability þ þ Different
matrices
n/a n/a n/a Info on scope of the
method (type of
material, DNA
amounts, inhibition)
Practicability þ þ Blind sample(s) n/a n/a n/a Ease of use of the
method, costs, need
for training/
equipment; transfer
to 2nd laboratory
Specificity
in silico þ þ Sequence
databases
n/a n/a n/a At least all available
GM events and plant
species
Experimentally þ þ 20 target and 20
non-target-
containing
materials (if
available);
preferentially
(C)RM
At least 2
per material
At least
1 run
Target-containing
materials: 100 HGE;
non-target
containing materials:
1000 HGEa
To be expressed as
false positive/
negative rate
Sensitivity
LOD6 þ þ (C)RM 6/dilution
point
At least
3 runs
At least 100, 50, 20,
10, 5, 2, 1, 0.1 HGE
LOD95% þ þ (C)RM 60/level 1 run/level LOD6, 1 level above,
1 level below
Each level tested is a
run on a separate
plate
LOD20asym  þ (C)RM or single
target plasmids
6/target At least
1 run
20 target HGE in a
total of 20,000 HGE:
ratio 1/1000
Other ratios can be
tested (1/500, 1/400,
1/200, 1/100, 1/50);
to be done for all
targets in the
multiplex
Amplification
efficiency (ε)*
 þ (C)RM or multiple-
target plasmid
6/dilution
point
At least
4 runs
5000, 2500, 1000,
500, 100, 50, 20, 10,
5, 2, 1 and 0.1 HGE
Upper end dilutions
are used (5000e100
HGE)
Linearity (R2)*  þ (C)RM or multiple-
target plasmid
6/dilution
point
At least
4 runs
5000, 2500, 1000,
500, 100, 50, 20, 10,
5, 2, 1 and 0.1 HGE
Upper end dilutions
are used (5000e100
HGE)
Robustness þ þ (C)RM 3 At least
1 run
20 HGE The different
conditions tested
need to be taken into
account to calculate
the number of runs
needed; only used as
informative data
Method performance parameters
False positive/
negative rate
þ þ 1 blind negative
sample (in 10
aliquots), 3 blind
positive samples
(in 10 aliquots
each); preferentially
(C)RM
2/sample
aliquot
1 run 0 HGE, 0.5
LOD95%, LOD95%,
2 LOD95%
The tested positive
levels should be
between 5 and 20
HGE; at least
acceptable results of
10 laboratories
should be obtained
þ: parameter to be evaluated; : parameter not to be evaluated (or optional*); (C)RM: (Certified) Reference Material; HGE: haploid genome
equivalent.
a If the non-target material is a GM CRM with a GM% below 100%, the non-target GM should be present at about 100 HGE.
122 S. Broeders et al. / Trends in Food Science & Technology 37 (2014) 115e126
Table 4. Checklist for validation of qualitative qPCR methods. Checklist showing the different steps to be addressed when performing validation
of qualitative qPCR methods including the essential (E) and desired (D) information to be reported in the validation dossier.
ITEM IMPORTANCE COMMENT
name of the target E
full name of the targeted sequence (accession number) D
length of the amplicon E
sequence of the amplicon E
location of the amplicon D
target containing materials E
non-target containing materials E
sequence alignment D
primer sequence E
probe sequence E n/a for SYBRGreen qPCR methods
probe labelling E n/a for SYBRGreen qPCR methods; give details on labelling
(e.g. FAM, MGB, Scorpion,…)
purification method D
manufacturer D
qPCR cycling conditions E
melting curve conditions E only for SYBRGreen qPCR methods
type of chemistry (SYBRGreen, TaqMan) E
singleplex/multiplex E
qPCR reagents E
qPCR volume E
qPCR mix setup E
qPCR instrument type D
manufacturer qPCR instrument D
DNA amount/reaction E
qPCR analysis program E
outlier test E
inhibition test E
results for the controls (PC, NTC,..) E
in-house E
     - applicability E
     - practicability E
     - specificity E
     - sensitivity E
     - PCR efficiency E optional for singleplex qPCR methods
     - linearity E optional for singleplex qPCR methods
     - robustness E
transferability study D or pre-validation step (if any)
collaborative trial E
     - false pos/neg rate E
     - robustness E
scope of the method E
type of matrix E
inhibition information E
analyte interference E
easy combination with other methods E
costs E
need for training E
blind sample analysis D
method transfer D
equipment needs D Essential if e.g. special chemistry or conditions are used
in silico specificity (BLAST, etc) E Give details: databases used,  parameters used, …
in situ specificity against target containing materials E Give details about the material used (CRM, RM, poorly
documented material, contamination check, …)
in situ specificity against non-target containing materials E Give details about the material used (CRM, RM, poorly
documented material, contamination check, …)
in situ specificity against other materials (bacteria, virus,…) D Give details about the material used (CRM, RM, poorly
documented material, contamination check, …)
confirmation (gel electrophoresis, sequencing,…) E
results expressed as false pos/neg rate E
LOD6 E
LOD95% E
LOD20assym E n/a for singleplex qPCR methods
PCR efficiency E optional for singleplex qPCR methods
linearity E optional for singleplex qPCR methods
change in primer concentration E
change in probe concentration E only for TaqMan qPCR methods
change in reaction volume E
change in annealing temperature E
change of instrument D
change of mastermix/qPCR reagents D
lab choice E
false pos/neg test E
type of samples E
level/content of each sample (HGE) E
number of samples E
choice of laboratories E
false pos/neg test E
type of samples E
level/content of each sample (HGE) E
number of samples E
Collaborative trial
Specificity
Data analysis
Sensitivity
Robustness
Transferability study
Applicability
Practicability
qPCR target 
information
qPCR 
oligonucleotides
qPCR reaction
Overview qPCR 
validation
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methods already used in the laboratory (i.e. performing
the analysis in the same run, on the same plate, using the
same reagents and conditions) should be considered. In
addition, the need for specific equipment and training of
the staff should be evaluated (ENGL, 2008; ISO 24276,
2006).
Under the specificity of a method is understood the prop-
erty of a method to respond exclusively to the character-
istic/analyte of interest (ISO 24276, 2006). This means
that in case of a GMO detection method, it should only
give a specific amplification signal with materials contain-
ing the target sequence. The evaluation of the specificity
needs to be done in silico as well as in situ (ENGL, 2008).
The sensitivity of a qPCR method is defined as the min-
imal analyte concentration that can be reliably detected but
not necessarily quantified (ISO 24276, 2006). It is ex-
pressed as the absolute limit of detection (LODabs). Two
types of absolute LOD can be determined namely the
LOD6 and the LOD95%. The first one is defined as the
HGE at which all six replicates give a similar and specific
positive amplification signal (AFNOR, 2008). The LOD95%
on the other hand is the LOD at which the analyte is de-
tected with 95% confidence, meaning that less than 5%
false negatives are allowed (Bustin et al., 2009). Further-
more, the asymmetric LOD (LOD20asym) is the ratio be-
tween the HGE of the tested target in comparison to the
fixed HGE level of all other targets which are considered
in the multiplex PCR assay (Huber et al., 2013).
The amplification efficiency (ε) is the amplification rate
that leads to a theoretical slope of 3.32 with a 100% effi-
ciency in each cycle (ENGL, 2008).
The linearity of a PCR reaction is expressed as the cor-
relation coefficient (R2) of the curve obtained by linear
regression analysis (ENGL, 2008).
The robustness of a method is a measure for its capacity
to remain unaffected (i.e. to provide a similar result) by
small but deliberate changes in the experimental conditions
as compared to the procedure (ENGL, 2008).Method performance parameters
False positive and false negative rates are the probability
that respectively a negative sample would be classified pos-
itive or a positive one would be regarded as negative
(CCMAS, 2010).Other definitions
A genetically modified organism (GMO) means an or-
ganism, with the exception of human beings, in which the
genetic material has been altered in a way that does not
occur naturally by mating and/or natural recombination
(Commission Directive 2001/18/EC).UGM has been used here to designate GM events that
are unauthorised in one country but authorised in another
for food and feed use.
Repeatability conditions are conditions under which the
independent results are obtained with the same method, on
identical test items, in the same laboratory, by the same
operator, using the same equipment within short intervals
of time (ISO 24276, 2006).
Reproducibility conditions are conditions under which
test results are obtained with the same method, on identical
test items, in different laboratories, with different operators,
using different equipments (ISO 24276, 2006).References
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